Accepting applications until August 1
Accepting applications until August 1
We invite you to join the ISOPT community to receive free updates, newsletters, and information on upcoming events.
On June 17, 2026, the leaders of the G7—joined by Brazil, Egypt, India, Kenya, and the Republic of Korea—issued a joint call to acceler...
Read ArticleLung cancer is increasingly diagnosed in never-smokers, suggesting that the current US Preventive Services Task Force (USPSTF) screenin...
Read ArticlePATROL, a multicenter prospective study published in BJU International on June 9, screens men who carry an inherited pathogenic variant...
Read Article
September 24-26, 2026
Hong Kong, China
World Cancer Congress 2026 will be organized in collaboration with the Hong Kong Anti-Cancer Society, a long-standing UICC member organization.
Mission Statement: ISOPT unites the world in cancer prevention and early detection. Through free multilingual virtual education, we help equip physicians, nurses, genetic counselors, patient advocates, policymakers, and at-risk individuals with the knowledge to assess risk, implement prevention strategies, detect cancer early, and provide multidisciplinary care. Reaching globally across all six continents—we transform education into lives saved.
Charitable Contributions and Other Payments. The International Society of Prevention and Treatment USA Inc. (“ISOPT USA”) is a qualified public charity under Section 501(c)(3) of the US Internal Revenue Code. Your contributions and support of our events are considered a charitable donation to the extent permitted by law. Tax ID Number 39-5091295.
Contact us: info@isopt.health
David Gandara, Professor at UC Davis Comprehensive Cancer Center, shared post by Edgardo Santos’s, FLASCO President at Florida Society of Clinical Oncology, on X, adding: “High risk factors in EGFR-mutated …
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X: …
Paul Brown, Radiation Oncologist at Mayo Clinic, shared a post on LinkedIn: “Editorial PCNSL Low dose WBRT: better cognitive outcomes (due to better CNS control?) 60yo OS benefit Consider LD-WBRT …
Hiba Al-Tarrah, Program Lead at Asia-Pacific Pediatric Hematology/Oncology Group, shared on LinkedIn: “Another great week at Harvard Medical School in the Global Health Leaders Program. Grateful to be learning alongside …
Bruce Waldholtz, Board Chair at Virginia Health Sciences, shared a post on LinkedIn: “The American Cancer Society Self Assesment Risk Tool – over 100,000 people have utilized this to asses …
Claudia Chisa, Oncology Resident at Prof. Dr. Agrippa Ionescu Emergency Clinical Hospital, shared on LinkedIn: “Best of ASCO. Inspire. Educate. Advance. A day spent alongside leading oncologists, all still curious, …